Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies

Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies

<p>Purpose: As whole-exome and whole-genome sequencing (WES/WGS) move into routine clinical practice, it is timely to review data that might inform the debate around secondary findings (SF) and the development of policies that maximize participant benefit.</p> <p>Methods:...

Bibliografski detalji
Glavni autori:	Ormondroyd, E, Mackley, M, Fletcher, B, Parker, M, Watkins, H
Format:	Journal article
Izdano:	Nature Publishing Group 2016

Slični predmeti

Views of rare disease participants in a UK whole-genome sequencing study towards secondary findings: a qualitative study
od: Mackley, M, i dr.
Izdano: (2018)

Whole Exome Sequencing in South Africa: Stakeholder Views on Return of Individual Research Results and Incidental Findings
od: Nicole Van Der Merwe, i dr.
Izdano: (2022-06-01)

Secondary findings in 421 whole exome-sequenced Chinese children
od: Wen Chen, i dr.
Izdano: (2018-09-01)

A clinical and ethical evaluation of secondary findings in the era of clinical whole-genome sequencing
od: Mackley, M
Izdano: (2017)

Whole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defects
od: Ben Johnson, i dr.
Izdano: (2016-10-01)

BALSA: integrated secondary analysis for whole-genome and whole-exome sequencing, accelerated by GPU
od: Ruibang Luo, i dr.
Izdano: (2014-06-01)

Whole exome sequencing in the rat
od: Julie F. Foley, i dr.
Izdano: (2018-06-01)

Secondary findings from whole-exome sequencing data in families with familial combined hyperlipidemia (FCHL)
od: Mana Zakeri, i dr.
Izdano: (2021-11-01)

Prenatal Whole Exome Sequencing; the Views of Clinicians, Scientists, Genetic Counsellors and Patient Representatives
od: Quinlan-Jones, E, i dr.
Izdano: (2016)

Whole Exome Sequencing in Atrial Fibrillation.
od: Steven A Lubitz, i dr.
Izdano: (2016-09-01)

Whole‐exome sequencing and immunohistochemistry findings in von Hippel–Lindau disease
od: Xiaopeng Guo, i dr.
Izdano: (2019-09-01)

Whole-exome sequencing study of hypospadias
od: Zhongzhong Chen, i dr.
Izdano: (2023-05-01)

The Role of Whole Exome Sequencing in Distinguishing Primary and Secondary Lung Cancers
od: Vokes NI, i dr.
Izdano: (2021-12-01)

P781: Prenatal whole exome sequencing: Diagnostic yield, syndromic landscape, and incidence and uptake of secondary findings
od: Kayleigh Avello, i dr.
Izdano: (2024-01-01)

P564: Doing no harm: Exploring the psychosocial impacts of receiving secondary findings from whole exome sequencing
od: Vanessa Rokoszak, i dr.
Izdano: (2024-01-01)

Opening Pandora's box? Ethical issues in prenatal whole genome and exome sequencing
od: Horn, R, i dr.
Izdano: (2017)

Whole-exome sequencing in evaluation of patients with venous thromboembolism
od: Eun-Ju Lee, i dr.
Izdano: (2017-07-01)

Apert's syndrome: Study by whole exome sequencing
od: Anjana Munshi, i dr.
Izdano: (2018-06-01)

The Application of Whole−Exome Sequencing in Patients With FUO
od: Wanru Guo, i dr.
Izdano: (2022-01-01)

Opt‐in for secondary findings as part of diagnostic whole‐exome sequencing: Real‐life experience from an international diagnostic laboratory
od: Minna Brunfeldt, i dr.
Izdano: (2023-08-01)

Whole-exome sequencing studies of nonfunctioning pituitary adenomas.
od: Newey, P, i dr.
Izdano: (2013)

Whole-exome sequencing of a pedigree segregating asthma
od: DeWan Andrew T, i dr.
Izdano: (2012-10-01)

From genotype to phenotype: Clinical assessment and participant perspective of a secondary genomic finding associated with long QT syndrome
od: Mackley, M, i dr.
Izdano: (2018)

Whole exome sequencing of a patient with metastatic hidradenocarcinoma and review of the literature
od: Eva Gupta, i dr.
Izdano: (2015-02-01)

Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome
od: Michael Rusch, i dr.
Izdano: (2018-09-01)

Diagnostic value of exome and whole genome sequencing in craniosynostosis
od: Miller, K, i dr.
Izdano: (2016)

Whole-exome sequencing of patients with juvenile myoclonic epilepsy
od: E. E. Timechko, i dr.
Izdano: (2022-10-01)

Whole‐Exome Sequencing Study of Extreme Phenotypes of NAFLD
od: Sarah E. Kleinstein, i dr.
Izdano: (2018-09-01)

Diagnostic Yield of Whole Exome Sequencing in Pediatric Dilated Cardiomyopathy
od: Pamela A. Long, i dr.
Izdano: (2017-08-01)

Whole-exome sequencing studies of nonhereditary (sporadic) parathyroid adenomas.
od: Newey, P, i dr.
Izdano: (2012)

Benchmarking of human Y-chromosomal haplogroup classifiers with whole-genome and whole-exome sequence data
od: Víctor García-Olivares, i dr.
Izdano: (2023-01-01)

Comparative analysis of whole exome sequencing kits for the canine genome.
od: Jinhee Jang, i dr.
Izdano: (2024-01-01)

Whole-exome sequencing of 228 patients with sporadic Parkinson's disease.
od: Sandor, C, i dr.
Izdano: (2017)

Assessing the impact of sequencing platforms and analytical pipelines on whole-exome sequencing
od: Yanping Sun, i dr.
Izdano: (2024-05-01)

Incidental and secondary findings in trio exome sequencing
od: Camille Cohen, i dr.
Izdano: (2024-07-01)

Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature
od: Schwarze, K, i dr.
Izdano: (2018)

Are whole exome and whole genome sequencing approaches cost-effective? A systematic review of the literature
od: Schwarze, K, i dr.
Izdano: (2018)

Identification of genetic variants in a pedigree associated with epilepsy by using whole exome sequencing and whole genome sequencing
od: Qin-Qin Zhang, i dr.
Izdano: (2021-06-01)

Evaluation of whole exome sequencing as an alternative to BeadChip and whole genome sequencing in human population genetic analysis
od: Zoltán Maróti, i dr.
Izdano: (2018-10-01)

Application of whole exome sequencing in patients with primary ciliary dyskinesia
od: Ke CHEN, i dr.
Izdano: (2024-12-01)